DJIA 17,683.58 -46.53 -0.26%
NASDAQ 4,991.94 -17.27 -0.34%
S&P 500 2,068.76 -8.02 -0.39%
market minute promo


company name or ticker

How Not To Handle Your Clinical Data

Why Shares of Orexigen Therapeutics, Inc. Cratered Today

Orexigen Therapeutics is crashing today following more bad news for its diet pill Contrave. Here's what investors need to know right now.

Orexigen Therapeutics (OREX) Highlighted As Weak On High Volume

Orexigen Therapeutics (OREX) Stock Continues to Sink on Contrave Study Fallout

Morning Market Losers

Benzinga's Top #PreMarket Losers

Tuesday's After-Hours Movers: Vertex Pharmaceuticals, Orexigen Therapeutics And More

Why It's Lights Out for Orexigen Therapeutics, Inc.

Orexigen Therapeutics shares tumble after the company announces the termination of a critical post-marketing approval study for Contrave.

Orexigen Therapeutics (OREX) Stock Declines After Halting Heart Benefit Tests

Arena Beats The Street On A Mixed Bag

See More Articles...